perindopril has been researched along with Innate Inflammatory Response in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Kostakoglu, U; Mercantepe, T; Topcu, A; Tumkaya, L; Uydu, HA; Yilmaz, HK | 1 |
| Alam, F; Aw, A; Bathgate, RAD; Ferens, D; Gaspari, TA; Hossain, MA; Jefferis, AM; Kemp-Harper, BK; Low, E; Praveen, P; Samuel, CS; Spizzo, I; Widdop, RE | 1 |
| Atak, M; Kostakoglu, U; Mercantepe, T; Topcu, A; Tumkaya, L; Uydu, HA | 1 |
| Aljuhani, N; El-Awady, MS; Hassan, MH; Ismail, RS | 1 |
| Barbarash, OL; Cherniavskaia, EIu; Zvereva, TN | 1 |
| Al-Sharea, A; Dart, AM; Du, XJ; Gao, XM; Han, LP; Kiriazis, H; Moore, S; Murphy, AJ; Su, Y; Tsai, A | 1 |
| Gilbert, RE; Kelly, DJ; Langham, RG; Tiauw, V; Wiggins, KJ; Zhang, Y | 1 |
| Bertrand, M; Blann, A; Ceconi, C; Cokkinos, D; Deckers, JW; Ferrari, R; Fox, KM; Kluft, C; Parrinello, G; Remme, WJ; Simoons, ML | 1 |
| Baysan, O; Celebi, H; Erinc, K; Hasimi, A; Isik, E; Karaeren, H; Koz, C; Oz, BS; Uzun, M; Yildirim, M; Yokusoglu, M | 1 |
| Kampoli, AM; Miliou, A; Oikonomou, E; Pallantza, Z; Papageorgiou, N; Paterakis, G; Stefanadis, C; Tousoulis, D; Vlachopoulou, A | 1 |
| Campbell, DJ; Chalmers, J; Colman, S; Jenkins, AJ; Kemp, BE; Lowe, GD; MacMahon, SW; Neal, BC; Patel, A; Rumley, A; Woodward, M | 1 |
| Antoniades, C; Kourtellaris, P; Papageorgiou, N; Siasos, G; Stefanadi, E; Stefanadis, C; Tentolouris, C; Tousoulis, D; Vasiliadou, C | 1 |
| Arfanakis, DA; Chlouverakis, G; Karkavitsas, NS; Kochiadakis, GE; Koukouraki, S; Marketou, ME; Stathaki, MI; Vardas, PE; Zacharis, EA | 1 |
| Dmitriev, VA; Masenko, VP; Oshchepkova, EV; Rogoza, AN; Titiov, VN | 1 |
| Akishita, M; Aoki, M; Horiuchi, M; Iwai, M; Shirakami, G; Toba, K; Wu, L; Zhang, L | 1 |
9 trial(s) available for perindopril and Innate Inflammatory Response
| Article | Year |
|---|---|
[Effect of perindopril on the processes of subclinical inflammation in patients with arterial hypertension and type 2 diabetes mellitus].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arterial Pressure; C-Reactive Protein; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypertension; Inflammation; Male; Middle Aged; Perindopril; Treatment Outcome; Vasodilation | 2013 |
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Artery Disease; Coronary Thrombosis; Double-Blind Method; Europe; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Inflammation Mediators; Kaplan-Meier Estimate; Perindopril; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
The effects of perindopril on aortic elasticity and inflammatory markers in hypertensive patients.
Topics: Antihypertensive Agents; Aorta; Biomarkers; Elasticity; Female; Humans; Hypertension; Inflammation; Male; Middle Aged; Perindopril | 2009 |
Comparable effects of pioglitazone and perindopril on circulating endothelial progenitor cells, inflammatory process and oxidative stress in patients with diabetes mellitus.
Topics: Aged; Diabetes Mellitus; Endothelial Cells; Female; Hematopoietic Stem Cells; Humans; Inflammation; Male; Middle Aged; Oxidative Stress; Perindopril; Pioglitazone; Thiazolidinediones | 2012 |
PERTINENT--perindopril-thrombosis, inflammation, endothelial dysfunction and neurohormonal activation trial: a sub-study of the EUROPA study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Biomarkers; Cells, Cultured; Coronary Artery Disease; Double-Blind Method; Endothelium, Vascular; Europe; Female; Humans; Inflammation; Male; Neurotransmitter Agents; Perindopril; Risk Factors; Thrombosis; Umbilical Veins | 2003 |
Associations of inflammatory and hemostatic variables with the risk of recurrent stroke.
Topics: Aged; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Inflammation; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Middle Aged; Odds Ratio; Perindopril; Placebos; Recurrence; Risk; Risk Factors; Stroke | 2005 |
Effects of irbesartan and perindopril on forearm reactive hyperemia and inflammatory process, in normotensive patients with coronary artery disease.
Topics: Antihypertensive Agents; Biphenyl Compounds; Blood Flow Velocity; Coronary Disease; E-Selectin; Enzyme-Linked Immunosorbent Assay; Female; Forearm; Humans; Hyperemia; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; Irbesartan; Lipids; Male; Middle Aged; Perindopril; Tetrazoles; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2008 |
Effect of angiotensin-converting enzyme inhibitors on systemic inflammation and myocardial sympathetic innervation in normotensive patients with type 2 diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Heart Ventricles; Humans; Inflammation; Male; Middle Aged; Oxidative Stress; Perindopril; Statistics, Nonparametric; Sympathetic Nervous System | 2008 |
[The activity of nonspecific inflammation in hypertensive patients].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Pressure; C-Reactive Protein; Circadian Rhythm; Diuretics; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypertension; Indapamide; Inflammation; Interleukin-6; Male; Middle Aged; Nephelometry and Turbidimetry; Perindopril; Treatment Outcome | 2007 |
8 other study(ies) available for perindopril and Innate Inflammatory Response
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
The cardioprotective effects of perindopril in a model of polymicrobial sepsis: The role of radical oxygen species and the inflammation pathway.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Inflammation; NF-kappa B; Oxygen; Perindopril; Rats; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha | 2022 |
The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy.
Topics: Animals; Cardiomyopathies; Hypertrophy; Inflammation; Male; Mice; Microvascular Rarefaction; Models, Theoretical; Perindopril; Relaxin | 2023 |
The protective effects of angiotensin-converting enzyme inhibitor against cecal ligation and puncture-induced sepsis via oxidative stress and inflammation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cecum; Extracellular Vesicles; Female; Glutathione; Inflammation; Lung; Oxidative Stress; Perindopril; Protective Agents; Punctures; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha | 2020 |
Modulatory effects of perindopril on cisplatin-induced nephrotoxicity in mice: Implication of inflammatory cytokines and caspase-3 mediated apoptosis.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Cisplatin; Cytokines; Inflammation; Kidney Diseases; Kidney Function Tests; Lipid Peroxidation; Male; Mice; Oxidative Stress; Perindopril | 2020 |
Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chemotaxis, Leukocyte; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rupture, Post-Infarction; Inflammation; Inflammation Mediators; Losartan; Male; Mice, 129 Strain; Monocytes; Myocardial Infarction; Myocardium; Neutrophil Infiltration; Neutrophils; Perindopril; Renin-Angiotensin System; Spleen; Time Factors | 2017 |
Perindopril attenuates tubular hypoxia and inflammation in an experimental model of diabetic nephropathy in transgenic Ren-2 rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Fibrosis; Hypoxia; Immunohistochemistry; Inflammation; Kidney Tubules; Macrophages; Nitroimidazoles; Osteopontin; Perindopril; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System; Time Factors | 2008 |
Angiotensin converting enzyme inhibitor restrains inflammation-induced vascular injury in mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Disease Models, Animal; Enzyme Inhibitors; Femoral Artery; Gene Expression; Inflammation; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Perindopril; RNA, Messenger | 2001 |